Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$693M |
| 2 |
Constellation Brands
STZ
|
+$368M |
| 3 |
Tesla
TSLA
|
+$332M |
| 4 |
NVIDIA
NVDA
|
+$300M |
| 5 |
Booking.com
BKNG
|
+$251M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charter Communications
CHTR
|
+$821M |
| 2 |
Netflix
NFLX
|
+$777M |
| 3 |
AbbVie
ABBV
|
+$583M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$477M |
| 5 |
FedEx
FDX
|
+$456M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.07% |
| 2 | Consumer Discretionary | 17.72% |
| 3 | Financials | 13.25% |
| 4 | Healthcare | 11.94% |
| 5 | Communication Services | 11.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AL
601
DELISTED
Air Lease Corp
AL
| $624K | ﹤0.01% |
+14,870
| New | +$645K |
|
602
BJ's Restaurants
BJRI
$1.44B
| $624K | ﹤0.01% |
10,401
-381
| -4% | -$20.4K |
|
|
TSS
603
DELISTED
Total System Services, Inc.
TSS
| $622K | ﹤0.01% |
7,361
-17,346
| -70% | -$1.49M |
|
604
Columbia Sportswear
COLM
$3.3B
| $621K | ﹤0.01% |
+6,787
| New | +$579K |
|
605
Genpact
G
$5.84B
| $617K | ﹤0.01% |
21,325
-35,897
| -63% | -$1.11M |
|
606
Sysco
SYY
$40.8B
| $616K | ﹤0.01% |
+9,027
| New | +$577K |
|
607
VeriSign
VRSN
$25.4B
| $616K | ﹤0.01% |
+4,479
| New | +$574K |
|
608
Encompass Health
EHC
$11.6B
| $615K | ﹤0.01% |
+11,412
| New | +$570K |
|
609
Capri Holdings
CPRI
$1.89B
| $614K | ﹤0.01% |
9,215
-18,619
| -67% | -$1.22M |
|
610
Nutanix
NTNX
$15.9B
| $612K | ﹤0.01% |
11,872
+2,667
| +29% | +$147K |
|
611
Match Group
MTCH
$9.16B
| $610K | ﹤0.01% |
+15,740
| New | +$660K |
|
612
Western Alliance Bancorporation
WAL
$9.11B
| $605K | ﹤0.01% |
+10,679
| New | +$640K |
|
613
Tenet Healthcare
THC
$22.3B
| $603K | ﹤0.01% |
+17,953
| New | +$558K |
|
614
Supernus Pharmaceuticals
SUPN
$2.75B
| $589K | ﹤0.01% |
9,837
-9,490
| -49% | -$492K |
|
615
NeoGenomics
NEO
$1.75B
| $573K | ﹤0.01% |
43,736
+6,888
| +19% | +$75.8K |
|
616
Phillips 66
PSX
$83B
| $570K | ﹤0.01% |
5,071
+2,866
| +130% | +$322K |
|
|
BIG
617
DELISTED
Big Lots, Inc.
BIG
| $569K | ﹤0.01% |
+13,618
| New | +$572K |
|
618
Nucor
NUE
$60.2B
| $568K | ﹤0.01% |
9,092
+5,629
| +163% | +$359K |
|
|
AMED
619
DELISTED
Amedisys
AMED
| $543K | ﹤0.01% |
6,355
-2,539
| -29% | -$186K |
|
620
PPG Industries
PPG
$26.5B
| $533K | ﹤0.01% |
5,143
+3,244
| +171% | +$344K |
|
621
ArcelorMittal
MT
$50.7B
| $527K | ﹤0.01% |
18,328
+11,362
| +163% | +$377K |
|
622
SiteOne Landscape Supply
SITE
$4.55B
| $515K | ﹤0.01% |
+6,132
| New | +$485K |
|
623
ASML
ASML
$609B
| $514K | ﹤0.01% |
2,595
-123
| -5% | -$24.7K |
|
|
B
624
DELISTED
Barnes Group Inc.
B
| $512K | ﹤0.01% |
8,686
-10,689
| -55% | -$634K |
|
625
Dorman Products
DORM
$4.27B
| $509K | ﹤0.01% |
7,457
-8,857
| -54% | -$597K |
|
Similar funds
Jennison Associates's Q2 2018 Portfolio in Review
As of Q2 2018, Jennison Associates held 740 positions worth $103B, up 2% from $101B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Jennison Associates withdrew a net $3.95B in Q2 2018, closing 87 positions and reducing 296 holdings. Its most notable exit was Great Plains Energy Incorporated, an estimated $152M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Jennison Associates opened a new position in AstraZeneca worth $677M.
- Jennison Associates's largest Q2 2018 buy was AstraZeneca: 9,637,084 shares worth $677M.
- Jennison Associates added most to Constellation Brands in Q2 2018, an estimated $368M increase.
- Jennison Associates's biggest Q2 2018 reduction was Charter Communications, cutting an estimated $821M.
- Jennison Associates fully exited Great Plains Energy Incorporated in Q2 2018, selling an estimated $152M.
- Jennison Associates's ten largest holdings make up 29% of its $103B portfolio in Q2 2018.
- Jennison Associates opened 89 new positions and closed 87 in Q2 2018.
- Jennison Associates's portfolio value rose 2% quarter-over-quarter to $103B.
Based on Jennison Associates's 13F filing for Q2 2018, filed 2 Aug 2018.